Physician profile
Robert Appling
NPI 1033432521
$3,872.21
in general payments reported to CMS, 2019-2025
18 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $23.50 · 2021: $1,855 · 2022: $964 · 2023: $310 · 2024: $227 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gentleman Orthopedic Solutions | $1,200.00 | 2021 | |
| Organogenesis INC. | $809.19 | 2019-2022 | |
| Smith+Nephew, INC. | $593.52 | 2021-2025 | Grafix Pl, Stravix, Oasis |
| Nevro Corp. | $546.44 | 2022-2023 | Senza |
| Paratek Pharmaceuticals, INC. | $155.68 | 2021 | |
| Convatec INC. | $136.40 | 2024 | |
| Treace Medical Concepts, INC. | $113.72 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $75.19 | 2020-2025 | Jublia |
| In2bones USA, LLC | $44.79 | 2021 | |
| Melinta Therapeutics, LLC | $37.53 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $32.29 | 2022 | |
| Nabriva Therapeutics, Plc | $31.19 | 2022 | |
| Horizon Therapeutics Plc | $28.57 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.26 | 2025 | Exparel |
| Genentech USA, INC. | $14.12 | 2025 | Susvimo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hypermed Imaging INC. | $13.51 | 2019 | |
| Kerecis Limited | $12.00 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kci USA, INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Appling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.